- Home
- FIS vs IQV Comparison
FIS vs IQV Comparison
Compare FIS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIS | IQV |
|---|---|---|
| Founded | 1968 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 36.4B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | FIS | IQV |
|---|---|---|
| Price | $65.30 | $218.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 17 |
| Target Price | $85.50 | ★ $237.59 |
| AVG Volume (30 Days) | ★ 2.9M | 1.4M |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.29 | ★ 7.30 |
| Revenue | $10,464,000,000.00 | ★ $15,904,000,000.00 |
| Revenue This Year | $5.80 | $6.14 |
| Revenue Next Year | $4.55 | $5.35 |
| P/E Ratio | $225.01 | ★ $29.86 |
| Revenue Growth | ★ 4.21 | 3.85 |
| 52 Week Low | $59.51 | $134.65 |
| 52 Week High | $85.85 | $234.30 |
Technical Indicators
Market Signals| Indicator | FIS | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 49.30 | 45.71 |
| Support Level | $64.91 | $214.01 |
| Resistance Level | $66.93 | $230.80 |
| Average True Range (ATR) | 1.41 | 5.57 |
| MACD | 0.17 | -1.26 |
| Stochastic Oscillator | 57.12 | 20.06 |
Price Performance
Historical ComparisonAbout FIS Fidelity National Information Services Inc.
Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.